Medical News TodayColorectal cancer: Treatment looks set for human clinical trialsMedical News TodayIn a study paper published in the journal Cancer Immunology Research, researchers at Thomas Jefferson University in Philadelphia, PA, report how they te… Continue reading
Business Wire (press release) |
Ferring Gains Option to FKD’s Phase III Bladder Cancer Gene Therapy Candidate
Genetic Engineering & Biotechnology News Ferring Pharmaceuticals said today it has acquired the option to secure global commercialization rights to FKD Therapies’ Phase III bladder cancer gene therapy candidate nadofaragene firadenovec/Syn3 (rAd-IFN/Syn3), through an agreement whose value was … Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer PatientsBusiness Wire (press release) Ferring commits to US oncology and cutting-edge researchThe Pharma Letter |
Express.co.uk |
Stem cell biological BREAKTHROUGH as scientists craft embryo without egg or sperm
Mirror.co.uk Scientists have announced a biological breakthrough by growing an embryo without either a sperm or an egg. Using two different types of stem cells, a team of researchers controversially grew them into the early stages of a human being in a petri dish … Scientists build ‘synthetic embryos’ – BBC NewsBBC News Cloning horror: Human clone fears as Euro scientists CREATE LIFE from ‘nothing’Express.co.uk Scientists Use Stem Cells To Create Embryo Without Sperm Or EggLADbible Phys.Org –The Japan Times all 14 news articles » |
labiotech (press release) (blog) |
FDA Backs Gene Therapy for Fatal Neurodegenerative Childhood Disease
labiotech (press release) (blog) Orchard Therapeutics has received a fourth Rare Pediatric Disease Designation from the FDA for its gene therapy candidate for metachromatic leukodystrophy. Orchard Therapeutics, based in London, has received a Rare Pediatric Disease Designation form … Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and morePMLiVE Orchard Therapeutics Receives Rare Pediatric Disease Designation for MLD TherapyRare Disease Report Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of …Markets Insider The Pharma Letter all 4 news articles » |